These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33107183)

  • 1. Lysis of cells of diverse bacteria by l,d-peptidases of Escherichia coli bacteriophages RB43, RB49 and T5.
    Shadrin VS; Machulin AV; Dorofeeva LV; Chernyshov SV; Mikoulinskaia GV
    J Appl Microbiol; 2021 Jun; 130(6):1902-1912. PubMed ID: 33107183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical synthesis of peptidoglycan mimetic-disaccharide-tetrapeptide conjugate and its hydrolysis by bacteriophage T5, RB43 and RB49 L-alanyl-D-glutamate peptidases.
    Azev V; Chulin A; Molchanov M; Prokhorov D; Mikoulinskaia G; Uversky VN; Kutyshenko V
    PeerJ; 2021; 9():e11480. PubMed ID: 34055493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of the active sites of orthologous endolysins of the Escherichia lytic bacteriophages T5, RB43, and RB49.
    Kutyshenko VP; Prokhorov DA; Mikoulinskaia GV; Molochkov NV; Yegorov AY; Paskevich SI; Uversky VN
    Int J Biol Macromol; 2021 Jan; 166():1096-1105. PubMed ID: 33159938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro study of the antibacterial effect of the bacteriophage T5 thermostable endolysin on Escherichia coli cells.
    Shavrina MS; Zimin AA; Molochkov NV; Chernyshov SV; Machulin AV; Mikoulinskaia GV
    J Appl Microbiol; 2016 Nov; 121(5):1282-1290. PubMed ID: 27501055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel thermally resistant endolysins encoded by pseudo T-even bacteriophages RB43 and RB49.
    Mikoulinskaia GV; Chernyshov SV; Shavrina MS; Molochkov NV; Lysanskaya VY; Zimin AA
    J Gen Virol; 2018 Mar; 99(3):402-415. PubMed ID: 29458521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
    Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
    J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria.
    Sui B; Wang X; Zhao T; Zhen J; Ren H; Liu W; Zhang X; Zhang C
    Appl Environ Microbiol; 2023 Jul; 89(7):e0058123. PubMed ID: 37338346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophage endolysins as a novel class of antibacterial agents.
    Borysowski J; Weber-Dabrowska B; Górski A
    Exp Biol Med (Maywood); 2006 Apr; 231(4):366-77. PubMed ID: 16565432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.
    Gerstmans H; Rodríguez-Rubio L; Lavigne R; Briers Y
    Biochem Soc Trans; 2016 Feb; 44(1):123-8. PubMed ID: 26862197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endolysins as antimicrobials.
    Nelson DC; Schmelcher M; Rodriguez-Rubio L; Klumpp J; Pritchard DG; Dong S; Donovan DM
    Adv Virus Res; 2012; 83():299-365. PubMed ID: 22748813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy.
    Oliveira H; São-José C; Azeredo J
    Viruses; 2018 May; 10(6):. PubMed ID: 29844287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial synergy between a phage endolysin and citric acid against the Gram-negative kiwifruit pathogen
    Sisson HM; Fagerlund RD; Jackson SA; Briers Y; Warring SL; Fineran PC
    Appl Environ Microbiol; 2024 Mar; 90(3):e0184623. PubMed ID: 38319087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of an endolysin - Like from Bacillus subtilis.
    Noormohammadi H; Abolmaali S; Astaneh SDA
    Microb Pathog; 2018 Jun; 119():221-224. PubMed ID: 29678741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multidomain architecture of a bacteriophage endolysin enables intramolecular synergism and regulation of bacterial lysis.
    Oechslin F; Menzi C; Moreillon P; Resch G
    J Biol Chem; 2021; 296():100639. PubMed ID: 33838182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria.
    Lim JA; Shin H; Heu S; Ryu S
    J Microbiol Biotechnol; 2014 Jun; 24(6):803-11. PubMed ID: 24690638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidoglycan degrading activity of the broad-range Salmonella bacteriophage S-394 recombinant endolysin.
    Legotsky SA; Vlasova KY; Priyma AD; Shneider MM; Pugachev VG; Totmenina OD; Kabanov AV; Miroshnikov KA; Klyachko NL
    Biochimie; 2014 Dec; 107 Pt B():293-9. PubMed ID: 25241254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of cationic dendrimers on antibacterial activity of phage endolysin against P. aeruginosa cells.
    Ciepluch K; Maciejewska B; Gałczyńska K; Kuc-Ciepluch D; Bryszewska M; Appelhans D; Drulis-Kawa Z; Arabski M
    Bioorg Chem; 2019 Oct; 91():103121. PubMed ID: 31310881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria.
    Zampara A; Sørensen MCH; Grimon D; Antenucci F; Vitt AR; Bortolaia V; Briers Y; Brøndsted L
    Sci Rep; 2020 Jul; 10(1):12087. PubMed ID: 32694655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lysis of bacterial cells in the process of bacteriophage release--canonical and newly discovered mechanisms].
    Woźnica WM; Bigos J; Łobocka MB
    Postepy Hig Med Dosw (Online); 2015 Jan; 69():114-26. PubMed ID: 25614679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taking aim on bacterial pathogens: from phage therapy to enzybiotics.
    Hermoso JA; García JL; García P
    Curr Opin Microbiol; 2007 Oct; 10(5):461-72. PubMed ID: 17904412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.